"Hope, like the gleaming taper’s light, Adorns and cheers our way;
And still, as darker grows the night, Emits a brighter ray."
— Oliver Goldsmith (1730?–1774)

Gleevec Resource Center
  GENERAL INFORMATION ABOUT GLEEVEC/GLIVEC
  • Gleevec Facts
  • Gleevec Development Timeline (graphic)
  • How Gleevec Works (graphic)
  • The BCR-ABL Translocation (graphic)
  • The Philadelphia Chromsome (picture)
  • Images of Gleevec Side Effects
  • "Taking Aim:" Fighting Against Cancers (graphic)
  • FDA Gleevec Approval Letter (Adobe Acrobat)
  • Gleevec Q&A
  • Gleevec Prescribing Information (Adobe Acrobat)
  • The new Gleevec tablets
  • Novartis letter to doctors about the new tablets
  • Getting Gleevec
  • Gleevec Slide Show
  • Medical Journal Articles About Gleevec — Lots More Added!
  • News Articles About Gleevec
  • CMLSupport.com Reports About Gleevec
  • Press Releases About Gleevec
  • Gleevec News From The American Society Of Hematology Annual Meetings (ASH)
  • More CML Resources
    		•
      GLEEVEC RESOURCES
  • National Cancer Institute
    Includes NCI information about Gleevec, plus clinical trial information.

  • Oregon Health and Sciences University
    OHSU's Dr. Brian Druker developed Gleevec. Read about Gleevec and ongoing clinical trials.

  • CMLhelp.org
    This site, supported by Novartis, "is a comprehensive resource for patients and families living with Chronic Myeloid Leukemia. Working together with the nation’s leading experts, our goal is to provide you with accurate and reliable medical information, and to offer you new insights into our understanding of CML and the promising breakthrough treatment, Signal Transduction Inhibitors (STIs)."

  • Novartis Oncology Web Site
    As STI571 is still at a relatively early phase of clinical testing and its safety and efficacy profile has not been determined, patients need to be monitored closely at centers that are experienced both with treating patients with CML and administering this agent.

  • The "Unofficial" STI/Glivec Site
    News, discussion groups, Glivec trials and more.

  • Chronic Myeloid Leukaemia European Support Group
    Geared toward non-U.S. residents; tackles issues unique to Europe and the UK, such as health insurance coverage problems.

  • The "Official" Gleevec site
    Site created by Novartis Oncology about Gleevec.

  • National Cancer Institute: "CML Information From PDQ For Health Professionals"
    Chronic myelogenous leukemia (CML) is one of a group of diseases called the myeloproliferative disorders. CML is not currently curable with conventional chemotherapy or immunotherapy. Allogeneic bone marrow transplantation from related or unrelated donors is the only known curative therapy. Survival after development of an accelerated phase is usually less than 1 year and after blastic transformation is only a few months, although patients with lymphoblastic transformation may live longer with appropriate treatment.

  • FDA Gleevec Information Center
    Information about Gleevec from the U.S. Food and Drug Administration.

  • Yahoo! CML Support Group
    Join an online discussion group for general CML issues through Yahoo!

  • ACOR Support Group
    Join an online discussion group for general CML issues through ACOR

  • Yahoo! Gleevec Support Group
    Join an online discussion group for Gleevec through Yahoo!

    		•






    Give me a holler





    Today Is:





    © 2000-2003 CMLSupport.com Inc. All rights reserved.

    These contents may not be reproduced in whole or in part in any medium without the express written permission of CMLSupport.com Inc. This site is best viewed with Internet Explorer.